MyFinsight
Home
Blog
About
Investment securities,
available-for-sale
$571,489K
(12.42%↑ Y/Y)
Cash and cash
equivalents
$384,985K
(51.79%↑ Y/Y)
Accounts receivable, net
$150,642K
(40.13%↑ Y/Y)
Prepaid expenses and
other current assets
$69,369K
Inventory
$32,372K
(23.92%↑ Y/Y)
Interest and other
receivables
$15,688K
(28.79%↑ Y/Y)
Total current assets
$1,224,545K
(27.48%↑ Y/Y)
Deferred tax assets
$240,679K
Intangible assets, net
$103,448K
(-9.52%↓ Y/Y)
Long-term inventory
$76,301K
(-9.60%↓ Y/Y)
Operating lease
right-of-use assets
$69,424K
(36.15%↑ Y/Y)
Property and equipment,
net
$17,107K
(382.29%↑ Y/Y)
Restricted cash
$7,846K
(-17.16%↓ Y/Y)
Other assets
$3,550K
(57.57%↑ Y/Y)
Total assets
$1,742,900K
(42.21%↑ Y/Y)
Total liabilities and
stockholders equity
$1,742,900K
(42.21%↑ Y/Y)
Total stockholders
equity
$1,306,609K
(58.88%↑ Y/Y)
Total liabilities
$436,291K
(8.21%↑ Y/Y)
Accumulated deficit
-$1,778,249K
(17.63%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$958K
(-335.96%↓ Y/Y)
Additional paid-in capital
$3,085,800K
(3.53%↑ Y/Y)
Total current
liabilities
$361,436K
(9.52%↑ Y/Y)
Operating lease
liabilities
$59,547K
(33.51%↑ Y/Y)
Other long-term
liabilities
$15,308K
(-46.38%↓ Y/Y)
Common stock, 0.0001
par value...
$16K
(0.00%↑ Y/Y)
Accrued liabilities
$316,870K
(2.24%↑ Y/Y)
Accounts payable
$44,566K
(121.75%↑ Y/Y)
Back
Back
Balance Sheet
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)
source: myfinsight.com